These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 26744893)
1. A Metabolic Study of Huntington's Disease. Nambron R; Silajdžić E; Kalliolia E; Ottolenghi C; Hindmarsh P; Hill NR; Costelloe SJ; Martin NG; Positano V; Watt HC; Frost C; Björkqvist M; Warner TT PLoS One; 2016; 11(1):e0146480. PubMed ID: 26744893 [TBL] [Abstract][Full Text] [Related]
2. A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease. Kalliolia E; Silajdžić E; Nambron R; Costelloe SJ; Martin NG; Hill NR; Frost C; Watt HC; Hindmarsh P; Björkqvist M; Warner TT PLoS One; 2015; 10(10):e0138848. PubMed ID: 26431314 [TBL] [Abstract][Full Text] [Related]
3. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting. Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease. Aziz NA; Pijl H; Frölich M; Schröder-van der Elst JP; van der Bent C; Roelfsema F; Roos RA Eur J Neurol; 2010 Feb; 17(2):280-8. PubMed ID: 19845749 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients. Salvatore E; Rinaldi C; Tucci T; Di Maio L; Di Somma C; Savastano S; Lombardi G; Filla A; Colao A; De Michele G J Neurol Neurosurg Psychiatry; 2011 May; 82(5):543-7. PubMed ID: 20884675 [TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington's disease patients. Russo CV; Salvatore E; Saccà F; Tucci T; Rinaldi C; Sorrentino P; Massarelli M; Rossi F; Savastano S; Di Maio L; Filla A; Colao A; De Michele G J Huntingtons Dis; 2013; 2(4):501-7. PubMed ID: 25062734 [TBL] [Abstract][Full Text] [Related]
7. Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease. Popovic V; Svetel M; Djurovic M; Petrovic S; Doknic M; Pekic S; Miljic D; Milic N; Glodic J; Dieguez C; Casanueva FF; Kostic V Eur J Endocrinol; 2004 Oct; 151(4):451-5. PubMed ID: 15476444 [TBL] [Abstract][Full Text] [Related]
8. Plasma melatonin is reduced in Huntington's disease. Kalliolia E; Silajdžić E; Nambron R; Hill NR; Doshi A; Frost C; Watt H; Hindmarsh P; Björkqvist M; Warner TT Mov Disord; 2014 Oct; 29(12):1511-5. PubMed ID: 25164424 [TBL] [Abstract][Full Text] [Related]
9. Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease. Martin B; Golden E; Carlson OD; Pistell P; Zhou J; Kim W; Frank BP; Thomas S; Chadwick WA; Greig NH; Bates GP; Sathasivam K; Bernier M; Maudsley S; Mattson MP; Egan JM Diabetes; 2009 Feb; 58(2):318-28. PubMed ID: 18984744 [TBL] [Abstract][Full Text] [Related]
10. The structural involvement of the cingulate cortex in premanifest and early Huntington's disease. Hobbs NZ; Pedrick AV; Say MJ; Frost C; Dar Santos R; Coleman A; Sturrock A; Craufurd D; Stout JC; Leavitt BR; Barnes J; Tabrizi SJ; Scahill RI Mov Disord; 2011 Aug; 26(9):1684-90. PubMed ID: 21557312 [TBL] [Abstract][Full Text] [Related]